|
Standard Prophylactic DLI Clinical Trials
1 actively recruiting trial across 1 location
Also known as: pro-DLI
Pipeline
Phase 1: 1
Top Sponsors
- University of Arizona1
Indications
- Acute Undifferentiated Leukemia (AUL)1
- Acute Lymphoid Leukemia1
- Chronic Myeloid Leukemia1
- Non-hodgkin Lymphoma1
- Myelodysplastic Syndrome1
Tucson, Arizona1 trial
Prophylactic DLI-X for Leukemia Relapse After HCT
The University of Arizona Cancer Center
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.